Skip to content

Kazia Therapeutics Limited.

KZIA

CIK 0001075880

← back to feed
Revenue (TTM)
42K
−98.2% YoY Q2 Dec 2025
Net Income (TTM)
−20.7M
+22.7% YoY Q2 Dec 2025
EPS Diluted (TTM)
−0.04
+62.8% YoY Q2 Dec 2025
Gross Margin
—
Q2 Dec 2025
Operating Margin
—
Q2 Dec 2025
Net Margin
-49,290.5%
Q2 Dec 2025
Free Cash Flow (TTM)
—
Q2 Dec 2025
Cash
69.46M
Q2 Dec 2025
Total Debt
—
Q2 Dec 2025
Shares Outstanding
809.42M sh
Q2 Dec 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings